AcroMetrix Overview
AcroMetrix provides a comprehensive line of molecular diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular testing in blood screening and clinical diagnostic laboratories. AcroMetrix...More»
AcroMetrix provides a comprehensive line of molecular diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular testing in blood screening and clinical diagnostic laboratories. AcroMetrix products and services are used by clinical testing laboratories, blood banks, and test manufacturers to demonstrate operator proficiency, certify new users, and monitor daily testing to ensure that results are verified before they are provided to the physician and patient. The company is dedicated to providing quality control products, services and systems to forward-looking companies and institutions engaged in establishing innovative technologies for pharmaceuticals, diagnostics, blood products and related fields.«Less
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 11/01/2004 | Series A | 3M | Unknown |
Products
| Name: | VeriSure® Pro Negative RNA |
| Product URL: | http://www.acrometrix.com/us/product/VeriSure-NEG |
| Description: | The VeriSure® Pro Negative RNA (HIV-1/HCV) External Quality Control (EQC) is intended for use with the Procleix HIV-1/HCV Screening and Discriminatory Assays and no other HCV assay for the detection of human immunodeficiency virus type 1 (HIV-1) RNA and hepatitis C virus (HCV) RNA in human plasma from donations of whole blood and blood components for transfusion. The VeriSure® Pro Negative RNA (HIV-1/HCV) External Quality Control is intended to provide a means of estimating precision and reproducibility of the Procleix HIV-1/HCV Screening and Discriminatory Assays and has the potential for detecting systematic deviations of the Procleix HIV-1/HCV assay for the qualitative determination of HIV-1 and HCV RNA. This product is for in-vitro diagnostic use only |
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Life Technologies Buys AcroMetrix
Jan 14, 2010 - 0 comments
AcroMetrix on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...

Profile
Opinions
